Abbott Labs stock price target raised to $146 by Wells Fargo on Medtech strength
PositiveFinancial Markets

Wells Fargo has raised its stock price target for Abbott Labs to $146, highlighting the company's strong performance in the medtech sector. This increase reflects confidence in Abbott's innovative products and market position, which is crucial for investors looking for growth in healthcare technology.
— Curated by the World Pulse Now AI Editorial System